Gout recovery after taking benzbromarone or febuxostat need to be based on the patient’s specific condition, whether there are contraindications and other factors to decide, these two drugs in the drug efficacy, indications, contraindications, etc. There are differences, can not directly determine which drug is better. 1. Efficacy: Benzbromarone is a drug that promotes uric acid excretion by inhibiting the reabsorption of uric acid in the renal tubules, and febuxostat can reduce uric acid levels by inhibiting uric acid synthesis. 2. Indications: Benzbromarone can be used in the treatment of primary hyperuricemia, gouty nodules and gouty intervals, while Febuxostat is only suitable for long-term treatment of hyperuricemia in patients with gout, and is not recommended for the treatment of asymptomatic hyperuricemia. 3. Contraindications: patients who are allergic to the components of febuxostat and patients being treated with azathioprine and mercaptopurine can not be treated with febuxostat, and patients who are allergic to phenylbromarone, patients with moderate-to-severe renal failure, and pregnant and lactating women are prohibited from using phenylbromarone treatment. Benzbromarone or febuxostat need to be used under the guidance of a physician, it is recommended that patients who need to take these two drugs to control the level of uric acid to the rheumatology and immunology department of the regular hospital for detailed consultation, do not take the drug on their own.